Calling For Consultant Cardiologists With an Interest in PCI Simulator Training

Calling For Consultant Cardiologists With an Interest in PCI Simulator Training

4th April 2022

In the interests of inclusivity, we would like to ask for volunteers to help with PCI Simulator Training at the Simulator Village at the British Cardiovascular Society Annual Conference this year (Mon 6th – Wed 8th June 2022, Manchester).

The five PCI/Coronary angiography Simulator training sessions are:

  • Monday 6th June AM (Session 1: 2x 1-hour sessions from 10:30-12:30)
  • Monday 6th June PM (Session 2: 3x 1-hour sessions from 13:30-16:30)
  • Tuesday 7th June AM (Session 3: 3x 1-hour sessions from 09:30-12:30)
  • Tuesday 7th June PM (Session 4: 3x 1-hour sessions from 13:30-16:30)
  • Wednesday 8th June AM (Session 5: 3x 1-hour sessions from 10:30-13:30)

If you can help, we would ask you get in contact by emailing PCI simulator training lead (Dr Mohammad Sahebjalal at msahebjalal@gmail.com) for more information and giving your availability at conference.

We will need up to 20 consultant trainers and we will allocate places on a first come first serve basis, so please get in touch if you would like to be involved.

Many thanks,

Dr Beth Freestone and Dr Mo Sahebjalal.

 

Radcliffe Cardiology’s Journal, ICR3, Announces a New Partnership with the British Cardiovascular Intervention Society (BCIS). 

Radcliffe Cardiology’s journal, Interventional Cardiology: Reviews, Research, Resources (ICR3), announces a new partnership with the British Cardiovascular Intervention Society (BCIS). 

This partnership will further ICR3’s purpose to support the knowledge network in the cardiovascular community. Working together will have a huge impact on the understanding and treatment of interventional medicine by providing the cardiology community with free access to high-quality review articles, original research and other resources that will help physicians on the frontline make more informed decisions – while BCIS can both extend the reach of that insight and widen the pool of professionals who can inform future thinking and research.

On the agreement, Dr Peter O’Kane, Editor-in-Chief of ICR3 based at the Royal Bournemouth Hospital, commented:

As a UK interventional cardiologist I am delighted that ICR3 is partnering with BCIS.

The strong tradition and exceptional quality of BCIS in shaping our national clinical standards, education and research programmes with membership across physicians and allied health professionals will provide the journal with an opportunity for wider readership and manuscript contribution.

This was already an exciting time for ICR3 as we have recently opened to accept original research article submissions. The association with BCIS will further enhance our commitment to providing outstanding educational resources and experience to the cardiology community across the globe.

BCIS President, Prof Nick Curzen, based at the Southampton University Hospital, UK added:

“I welcome the partnership between ICR3 and BCIS, which will facilitate an exciting and novel platform for dissemination of original research, state-of-the-art output and news.

“We welcome the journal’s ambition for the highest academic standards moving forward and this resonates with the needs of our members, especially the research activities. This partnership will offer a range of mutually beneficial opportunities.” 

ICR3 is open to new content from authors wishing to submit an article which can be done online https://www.editorialmanager.com/icr/default1.aspx

About Interventional Cardiology: Reviews, Research, Resources

Interventional Cardiology: Reviews, Research, Resources (ICR3) is a PubMed indexed, peer-reviewed open access journal that publishes articles continuously on ICRjournal.com. It aims to assist time-pressured physicians to stay abreast of key advances and opinions in interventional cardiology. ICR3 comprises balanced and comprehensive articles written by leading authorities while providing updates on a range of salient issues to support physicians in developing their knowledge and effectiveness in day-to-day clinical practice. The journal endeavours to support the continuous medical education of specialist and general cardiologists and disseminate knowledge of the field to the wider cardiovascular community.

About British Cardiovascular Intervention Society

The British Cardiovascular Intervention Society (BCIS) promotes education, training and research in cardiovascular intervention as well as developing and upholding both clinical and professional standards. BCIS provides a large array of educational material from a variety of sources, presentations, audio casts and webcasts from previous conferences including both AHP and ACI, as well as the publication of clinical cases, reviews and news.

About Radcliffe Cardiology

Radcliffe Cardiology provides free access to peer-reviewed content from industry-leading journals

Arrhythmia & Electrophysiology Review (AER), Cardiac Failure Review (CFR), European Cardiology

Review (ECR), Interventional Cardiology: Reviews, Research, Resources (ICR3), US Cardiology Review

(USC) and Journal of Asian Pacific Society of Cardiology (JAPSC). Alongside other digital and multimedia content, Cardiology Journals | Cardiologist Education | Radcliffe Cardiology aims to support physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity.

Joint statement by Presidents of BCS/BCIS/SCTS about interpretation of the 2021 AHA/ACC/SCAI Coronary Artery Revascularization guidelines

Joint statement by Presidents of BCS/BCIS/SCTS about interpretation of the 2021 AHA/ACC/SCAI Coronary Artery Revascularization guidelines

1st March 2022

25th February 2022

Dear Member

Joint statement by Presidents of BCS/BCIS/ SCTS to members about interpretation of the 2021 AHA/ACC/SCAI Coronary Artery Revascularization guidelines

The AHA/ACC/SCAI Coronary Revascularisation guidelines published in December 2021 have proved contentious, and have precipitated this statement.

We would like to reinforce to all our members that we encourage them to continue to assess and manage patients requiring coronary revascularisation according to the principles set out in “Getting the Best from the Heart Team” by the Association of Cardiothoracic Anaesthetists and Critical Care, British Cardiovascular Society, British Cardiovascular Intervention Society, the British Heart Valve Society and the Society for Cardiothoracic Surgery in Great Britain and Ireland.

We recommend that non-emergency cases involving left main or multivessel disease should be discussed at an appropriate MDM, and a suggested management plan/options should then be considered as part of a process of shared decision-making with the patient.  Specifically, we do not agree with the downgraded Level of Evidence for the use of CABG as laid out in the recent AHA/ACC/SCAI guideline document.

The appropriate management of patients with left main or multivessel disease will be optimally achieved via the MDM process and after informed discussion with the patient.

With best wishes

 

Prof. Tony Gershlick: His life in interventional cardiology…and all that jazz

Prof. Tony Gershlick: His life in interventional cardiology…and all that jazz

15th February 2022

25th February 2022

Dear Member

Joint statement by Presidents of BCS/BCIS/ SCTS to members about interpretation of the 2021 AHA/ACC/SCAI Coronary Artery Revascularization guidelines

The AHA/ACC/SCAI Coronary Revascularisation guidelines published in December 2021 have proved contentious, and have precipitated this statement.

We would like to reinforce to all our members that we encourage them to continue to assess and manage patients requiring coronary revascularisation according to the principles set out in “Getting the Best from the Heart Team” by the Association of Cardiothoracic Anaesthetists and Critical Care, British Cardiovascular Society, British Cardiovascular Intervention Society, the British Heart Valve Society and the Society for Cardiothoracic Surgery in Great Britain and Ireland.

We recommend that non-emergency cases involving left main or multivessel disease should be discussed at an appropriate MDM, and a suggested management plan/options should then be considered as part of a process of shared decision-making with the patient.  Specifically, we do not agree with the downgraded Level of Evidence for the use of CABG as laid out in the recent AHA/ACC/SCAI guideline document.

The appropriate management of patients with left main or multivessel disease will be optimally achieved via the MDM process and after informed discussion with the patient.

With best wishes

 

 

This meeting is being organised free of charge by Millbrook Medical Conferences alongside some of Tony’s colleagues and friends, with no involvement of BCIS as a society. Tony was a pioneer within Interventional Cardiology and impacted the lives of many of our members, which is why we wanted to share details of this day with our membership.

The British Heart Foundation SENIOR-RITA Trial Invitation

The British Heart Foundation SENIOR-RITA Trial Invitation 

The BHF SENIOR-RITA trial is an ongoing BHF funded clinical trial evaluating a conservative versus invasive strategy in the management of NSTEMI among patients aged 75 years and over. Given the pandemic caused disruptions, the BHF have awarded a costed extension to recruitment to achieve a total sample size of 1668 participants. To date 1310 participants have been recruited in the trial. We are looking for enthusiastic new sites across the UK to help us recruit the remaining ~350 participants. The trial is currently on the NIHR Managed Recovery Initiative. If you/hospital are interested, please contact Dr. Vijay Kunadian vijay.kunadian@newcastle.ac.uk

Link to the trial:

https://clinicaltrials.gov/ct2/show/NCT03052036

https://www.bhf.org.uk/research-projects/the-older-patients-randomised-interventional-trial-in-acute-nonst-elevation-myocardial-infarctionthe-seniorrita-trial

BHF Clinical Research Collaborative support for CTU engagement

BHF Clinical Research Collaborative support for CTU engagement

24th August 2021

BHF CRC Consultancy Support with CTUs

The BHF CRC offer UK researchers the opportunity to consult with a leading CTU to address questions in, and refine the design of, research projects. Eligible projects must be towards the later stages of development (rather than conceptual) and be of sufficient scale or merit that they will attract the support of one of our established Research Groups. Smaller scale studies or those in early-stage development are not applicable for this initiative and should be directed towards the NIHR Research Design Service. Researchers can choose the CTU they would like to work with from the list of the BHF CRC’s partnered CTUs found here.

We hope that this initiative will allow researchers to:

  • Establish a relationship with a premier CTU, best suited to their proposed study
  • Promote CTU involvement at the appropriate stage in study design
  • Provide answers to key questions in methodology, statistics or practical design to further study development.

For more information on how to apply to this scheme, please visit the BHF CRC webpage https://bhfcrc.org/clinical-trials-units/ or contact enquiries@bhfcrc.org.

Pre-procedural management of oral anticoagulant therapy for non-emergent PCI: a survey of current practice in the UK

Pre-procedural management of oral anticoagulant therapy for non-emergent PCI: a survey of current practice in the UK

13th May 2021

Dear colleague,

We would like help understanding how we the cardiovascular community are currently managing in-patients on oral anticoagulants undergoing non-emergent PCI & how this may reflect (or not) published guidelines.

The questionnaire is endorsed by BCIS & takes little time to complete (~ 4 minutes). It is intended for consultant interventional cardiologists in the UK.

While guidelines on the management of such patients have been published, the recommendations are not consistent, hence our need to know what everyone is actually doing.

The responses will formulate our understanding of what is happening in everyday practice, & to what degree this is at variance with guideline management. The results will be fed back to participants.

Please access the survey by clicking on the link below:

Thank you for your time.

Kind regards,

Dr Annette Maznyczka (ST6 intervention fellow, Portsmouth)

Dr Alex Hobson (Consultant interventional cardiologist, Portsmouth)

Prof Nick Curzen (Consultant interventional cardiologist, Southampton & BCIS president)

Dr Peter Haworth (Consultant interventional cardiologist, Portsmouth)

Upcoming External Meetings

Upcoming External Meetings

27th April 2021

CTO LIVE AID

CTO LIVE AID 2020 was a great success and the organisers alongside BCIS ask for our support for “CTO LIVE AID feat Bifurcation”. Not only will you be able to follow CTO PCI but also Bifurcation procedures.

• 26 experts interventional cardiologists in a unique “World Tour”
• 10 CTO live cases from 9 international centers
• 16 Bifurcation live cases from 16 international centers
• Over a 16 hours lapse

MLCTO 2021

The ML CTO Course Directors are pleased to invite you to the 6th Edition of the Multi-Level CTO Course during July 1-3, 2021 in Nice, France.

Thanks to the success of  last year’s digital experience and giving the complexity of the health situation, this edition is designed with the aim to reach all of the CTO PCI community by hosting a hybrid event over the 3-day meeting: with speakers, chairs and operators attending live and remotely.

ECC 2021

Bringing togethr the most amazing educational complication cases from around the globe, to be presented onsite or remote, and listening to particular lectures, unusual topics, from our faculty.

This 14th edition will be a particular challenge for sure. But we can count on the support of our valued industry partners and we trust on the community by submitting and sharing their clinical cases.

ESC Heart & Stroke 2021

ESC Heart & Stroke 2021

6th April 2021

2-4th June 2021 | E-Conference

Who?

The International Conference of the ESC Council on Stroke is an educational conference for clinicians. It is designed not only for cardiologists, but also for neurologists, radiologists, vascular surgeons, neurosurgeons whose work has a component in “stroke”.

When?

2-4 June 2021 – Afternoon sessions

This format will allow the members to join the sessions that are professionally most relevant to their daily practice

What?

KOL‘s from a wide range of specialties will discuss multidisciplinary and focused aspects with emphasis on the latest developmentspractical experience sharing and guidelines illustration in the light of the latest research

 

Join this interactive conference and benefit of the opportunity to present your poster and share your work with large ESC family audience

BCS Emerging Leaders Programme

BCS Emerging Leaders Programme

26th March 2021

Call for Expressions of Interest – Nurses and Radiographers

Dear Colleagues

The BCS is seeking applications from nurses and radiographers who would be interested in being delegates on this highly prestigious course for EMERGING LEADERS. The objective is to provide training and support for experienced Cath Lab nurses and radiographers with the ambition to seek/apply for senior leadership roles.

I should point out that the opportunity is also open to physiologists, but the BCS is pursuing this via their own physiologists’ society route.

The following links provide the draft programme for this year’s event and an idea of the selection criteria and application.

This is an exciting opportunity for BCIS members.

Good luck!

Prof. Nick Curzen
President, British Cardiovascular Intervention Society